banner
RIP kinase inhibitor RIPK1-IN-7, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ171

RIP kinase inhibitor RIPK1-IN-7, Purity ≥98%

Synonym: 2300982-44-7; RIPK1-IN-7; 1-(5-(4-Amino-7-ethyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)indolin-1-yl)-2-(3-(trifluoromethoxy)phenyl)ethan-1-one; RIP kinase inhibitor

  • CAS Number: 2300982-44-7
  • Compound CID: 137321158
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
RIPK1-IN-7 is a compound that targets RIP kinases and is a critical regulator of various cellular processes, including apoptosis, necroptosis, and inflammation.
Molecular Weight
481.47
Molecular Formula
C25H22F3N5O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
RIPK1-IN-7 can be studied for its role in blocking RIPK1 activity and modulating necroptotic pathways.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0